Tapewire

Nasdaq · USD

SQFT

Presidio Property Trust, Inc.

Export transactions ↓
Tapewire entity
8487
SEC CIK
0001080657
Parsed reports
235

Last 12 months

Inside the activity.

4 purchase rows · 3 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202530
Jan 202600
Feb 202600
Mar 202600
Apr 202602
May 202600
Jun 202601
Jul 202600
Aug 202600
Sep 202610
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
June 01, 2022 Filed Oct 5, 2022 20:36 UTC
Bentzen Edwin H IVChief Accounting Officer
GrantCOMMON STOCK - SERIES A 2,000 $3.22 $6,440.00
Disclosure

SEC source: 0001209191-22-052764 · doc4.xml · nonDerivative · entry 1

Bentzen Edwin H IV · CIK 0001695081 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,431

F1 · shares: Restricted shares granted pursuant to the Company's 2017 Incentive Award Plan. These shares are restricted for one (1) year.

Read SEC document
May 25, 2022 Filed May 26, 2022 17:06 UTC
Heilbron Jack KendrickDirector · CEO and President
PurchaseSQFTW 10,000 $0.16 $1,600.00
Disclosure

SEC source: 0001209191-22-032104 · doc4.xml · nonDerivative · entry 1

Heilbron Jack Kendrick · CIK 0001437208 · Director · CEO and President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,000

Read SEC document
May 19, 2022 Filed May 23, 2022 15:19 UTC GrantCommon Stock - Series A 5,343 $3.74 $19,982.82
Disclosure

SEC source: 0001209191-22-031259 · doc4.xml · nonDerivative · entry 1

DURFEY JAMES ROBERT · CIK 0001797416 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 52,835

Read SEC document
May 19, 2022 Filed May 23, 2022 15:11 UTC GrantCommon Stock - Series A 1,336 $3.74 $4,996.64
Disclosure

SEC source: 0001209191-22-031257 · doc4.xml · nonDerivative · entry 1

BARNES JENNIFER A · CIK 0001806097 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,888

Read SEC document
May 19, 2022 Filed Oct 3, 2022 21:26 UTC GrantCommon Stock - Series A 1,336 $3.74 $4,996.64
Disclosure

SEC source: 0001209191-22-051914 · doc4.xml · nonDerivative · entry 1

BARNES JENNIFER A · CIK 0001806097 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,888

F1 · shares: Restricted shares granted pursuant to the Company's 2017 Incentive Award Plan. These shares are restricted for one (1) year.

Read SEC document
January 06, 2022 Filed Jan 7, 2022 18:25 UTC
Heilbron Jack KendrickDirector · CEO and President
Tax withholdingCommon Stock - Series A 10,804 $3.76 $40,666.26
Disclosure

SEC source: 0001209191-22-002344 · doc4.xml · nonDerivative · entry 4

Heilbron Jack Kendrick · CIK 0001437208 · Director · CEO and President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 306,217

F4 · shares: Reporting Person elected to have the Company withhold shares otherwise issuable to cover tax liabilities in connection with shares that vested on 12/31/2021 and 01/03/2022.

F5 · price: Reflects weighted average of sales price per share to cover tax liabilities for shares scheduled that vested on 12/31/2021 and 01/03/2022

F6 · balance_after: The balance includes: (i) 600 shares (less than 0.5% of holdings reported) held by or FBO the Reporting Person's grandchildren, and (ii) shares held in Reporting Person's IRA.

Read SEC document
January 06, 2022 Filed Jan 7, 2022 18:07 UTC
Dubose Larry GeneDirector · D&O of affiliated companies
Tax withholdingCommon Stock - Series A 6,425 $3.76 $24,183.70
Disclosure

SEC source: 0001209191-22-002324 · doc4.xml · nonDerivative · entry 4

Dubose Larry Gene · CIK 0001438084 · Director · D&O of affiliated companies

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 144,574

F4 · shares: Reporting Person elected to have the Company withhold shares otherwise issuable to cover tax liabilities in connection with shares that vested on 12/31/2021 and 01/03/2022.

F5 · price: Reflects weighted average of sales price per share to cover tax liabilities for shares scheduled that vested on 12/31/2021 and 01/03/2022.

Read SEC document
January 06, 2022 Filed Jan 7, 2022 17:55 UTC
Sragovicz AdamChief Financial Officer
Tax withholdingCommon Stock - Series A 6,051 $3.71 $22,427.43
Disclosure

SEC source: 0001209191-22-002321 · doc4.xml · nonDerivative · entry 4

Sragovicz Adam · CIK 0001727723 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 132,170

F4 · shares: Reporting Person elected to have the Company withhold shares otherwise issuable to cover tax liabilities in connection with shares that vested on 12/31/2021 and 01/03/2022.

F5 · price: Reflects weighted average of sales price per share to cover tax liabilities for shares scheduled that vested on 12/31/2021 and 01/03/2022.

Read SEC document
January 06, 2022 Filed Jan 7, 2022 17:44 UTC
KATZ GARY MORRISSVP, Asset Management
Tax withholdingCOMMON STOCK - SERIES A 9,076 $3.76 $34,162.06
Disclosure

SEC source: 0001209191-22-002320 · doc4.xml · nonDerivative · entry 4

KATZ GARY MORRIS · CIK 0001764243 · SVP, Asset Management

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 158,958

F4 · shares: Reporting Person elected to have the Company withhold shares otherwise issuable to cover tax liabilities in connection with shares that vested on 12/31/2021 and 01/03/2022.

F5 · price: Reflects weighted average of sales price per share to cover tax liabilities for shares scheduled that vested on 12/31/2021 and 01/03/2022.

Read SEC document
January 04, 2022 Filed Jan 7, 2022 18:25 UTC
Heilbron Jack KendrickDirector · CEO and President
Tax withholdingCommon Stock - Series A 9,598 $3.83 $36,768.98
Disclosure

SEC source: 0001209191-22-002344 · doc4.xml · nonDerivative · entry 3

Heilbron Jack Kendrick · CIK 0001437208 · Director · CEO and President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 317,021

F4 · shares: Reporting Person elected to have the Company withhold shares otherwise issuable to cover tax liabilities in connection with shares that vested on 12/31/2021 and 01/03/2022.

F5 · price: Reflects weighted average of sales price per share to cover tax liabilities for shares scheduled that vested on 12/31/2021 and 01/03/2022

Read SEC document
January 04, 2022 Filed Jan 7, 2022 18:07 UTC
Dubose Larry GeneDirector · D&O of affiliated companies
Tax withholdingCommon Stock - Series A 3,967 $3.83 $15,197.18
Disclosure

SEC source: 0001209191-22-002324 · doc4.xml · nonDerivative · entry 3

Dubose Larry Gene · CIK 0001438084 · Director · D&O of affiliated companies

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 150,999

F4 · shares: Reporting Person elected to have the Company withhold shares otherwise issuable to cover tax liabilities in connection with shares that vested on 12/31/2021 and 01/03/2022.

F5 · price: Reflects weighted average of sales price per share to cover tax liabilities for shares scheduled that vested on 12/31/2021 and 01/03/2022.

Read SEC document
January 04, 2022 Filed Jan 7, 2022 17:55 UTC
Sragovicz AdamChief Financial Officer
Tax withholdingCommon Stock - Series A 7,170 $3.83 $27,467.55
Disclosure

SEC source: 0001209191-22-002321 · doc4.xml · nonDerivative · entry 3

Sragovicz Adam · CIK 0001727723 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 138,221

F4 · shares: Reporting Person elected to have the Company withhold shares otherwise issuable to cover tax liabilities in connection with shares that vested on 12/31/2021 and 01/03/2022.

F5 · price: Reflects weighted average of sales price per share to cover tax liabilities for shares scheduled that vested on 12/31/2021 and 01/03/2022.

Read SEC document
January 04, 2022 Filed Jan 7, 2022 17:44 UTC
KATZ GARY MORRISSVP, Asset Management
Tax withholdingCOMMON STOCK - SERIES A 3,608 $3.83 $13,821.89
Disclosure

SEC source: 0001209191-22-002320 · doc4.xml · nonDerivative · entry 3

KATZ GARY MORRIS · CIK 0001764243 · SVP, Asset Management

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 168,034

F4 · shares: Reporting Person elected to have the Company withhold shares otherwise issuable to cover tax liabilities in connection with shares that vested on 12/31/2021 and 01/03/2022.

F5 · price: Reflects weighted average of sales price per share to cover tax liabilities for shares scheduled that vested on 12/31/2021 and 01/03/2022.

Read SEC document
January 03, 2022 Filed Jan 5, 2022 23:02 UTC
Bentzen Edwin H IVChief Accounting Officer
Tax withholdingCOMMON STOCK - SERIES A 242 $3.83 $927.08
Disclosure

SEC source: 0001209191-22-001913 · doc4.xml · nonDerivative · entry 2

Bentzen Edwin H IV · CIK 0001695081 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,431

F4 · shares: Reporting Person elected to have the Company withhold shares otherwise issuable to cover tax liabilities.

F5 · price: Reflects weighted average of sales price per share to cover tax liabilities.

Read SEC document
January 03, 2022 Filed Jan 5, 2022 23:02 UTC
Bentzen Edwin H IVChief Accounting Officer
GrantCOMMON STOCK - SERIES A 21,673 $3.81 $82,574.13
Disclosure

SEC source: 0001209191-22-001913 · doc4.xml · nonDerivative · entry 1

Bentzen Edwin H IV · CIK 0001695081 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,673

F1 · shares: Restricted shares granted pursuant to the Company's 2017 Incentive Award Plan. These shares vest evenly over a three (3) year period at the end of each calendar year.

F2 · price: Reflects trailing 20 day average closing price for Grants Issued.

F3 · balance_after: Reflects additional 6,000 shares granted on 3/1/2021 that were accidentally omitted.

Read SEC document
January 03, 2022 Filed Jan 5, 2022 22:05 UTC GrantCOMMON STOCK - SERIES A 8,117 $3.81 $30,925.77
Disclosure

SEC source: 0001209191-22-001787 · doc4.xml · nonDerivative · entry 1

Rollings Sumner James · CIK 0001437209 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 62,813

Read SEC document
January 03, 2022 Filed Jan 5, 2022 21:58 UTC
Bruen DavidDirector
GrantCOMMON STOCK - SERIES A 8,467 $3.81 $32,259.27
Disclosure

SEC source: 0001209191-22-001760 · doc4.xml · nonDerivative · entry 1

Bruen David · CIK 0001456713 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 46,836

Read SEC document
January 03, 2022 Filed Jan 5, 2022 21:56 UTC GrantCOMMON STOCK - SERIES A 8,117 $3.81 $30,925.77
Disclosure

SEC source: 0001209191-22-001757 · doc4.xml · nonDerivative · entry 1

DURFEY JAMES ROBERT · CIK 0001797416 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 47,492

Read SEC document
January 03, 2022 Filed Jan 5, 2022 21:40 UTC GrantCOMMON STOCK - SERIES A 8,117 $3.81 $30,925.77
Disclosure

SEC source: 0001209191-22-001737 · doc4.xml · nonDerivative · entry 1

BARNES JENNIFER A · CIK 0001806097 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,552

Read SEC document
January 03, 2022 Filed Jan 7, 2022 18:25 UTC
Heilbron Jack KendrickDirector · CEO and President
GrantCommon Stock - Series A 26,271 $3.81 $100,092.51
Disclosure

SEC source: 0001209191-22-002344 · doc4.xml · nonDerivative · entry 2

Heilbron Jack Kendrick · CIK 0001437208 · Director · CEO and President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 326,619

F3 · shares: Restricted shares granted pursuant to the Company's 2017 Incentive Award Plan. These shares vest on the date of grant.

F2 · price: Reflects trailing 20 day average closing price for grants issued.

Read SEC document
January 03, 2022 Filed Jan 7, 2022 18:25 UTC
Heilbron Jack KendrickDirector · CEO and President
GrantCommon Stock - Series A 101,508 $3.81 $386,745.48
Disclosure

SEC source: 0001209191-22-002344 · doc4.xml · nonDerivative · entry 1

Heilbron Jack Kendrick · CIK 0001437208 · Director · CEO and President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 300,348

F1 · shares: Restricted shares granted pursuant to the Company's 2017 Incentive Award Plan. These shares vest evenly over a three (3) year period at the end of each calendar year.

F2 · price: Reflects trailing 20 day average closing price for grants issued.

Read SEC document
January 03, 2022 Filed Jan 7, 2022 18:07 UTC
Dubose Larry GeneDirector · D&O of affiliated companies
GrantCommon Stock - Series A 21,017 $3.81 $80,074.77
Disclosure

SEC source: 0001209191-22-002324 · doc4.xml · nonDerivative · entry 2

Dubose Larry Gene · CIK 0001438084 · Director · D&O of affiliated companies

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 154,966

F3 · shares: Restricted shares granted pursuant to the Company's 2017 Incentive Award Plan. These shares vest on the date of grant.

F2 · price: Reflects trailing 20 day average closing price for grants issued.

Read SEC document
January 03, 2022 Filed Jan 7, 2022 18:07 UTC
Dubose Larry GeneDirector · D&O of affiliated companies
GrantCommon Stock - Series A 10,508 $3.81 $40,035.48
Disclosure

SEC source: 0001209191-22-002324 · doc4.xml · nonDerivative · entry 1

Dubose Larry Gene · CIK 0001438084 · Director · D&O of affiliated companies

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 133,949

F1 · shares: Restricted shares granted pursuant to the Company's 2017 Incentive Award Plan. These shares vest evenly over a three (3) year period at the end of each calendar year.

F2 · price: Reflects trailing 20 day average closing price for grants issued.

Read SEC document
January 03, 2022 Filed Jan 7, 2022 17:55 UTC
Sragovicz AdamChief Financial Officer
GrantCommon Stock - Series A 14,712 $3.81 $56,052.72
Disclosure

SEC source: 0001209191-22-002321 · doc4.xml · nonDerivative · entry 2

Sragovicz Adam · CIK 0001727723 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 145,391

F3 · shares: Restricted shares granted pursuant to the Company's 2017 Incentive Award Plan. These shares vest on the date of grant.

F2 · price: Reflects trailing 20 day average closing price for grants issued.

Read SEC document
January 03, 2022 Filed Jan 7, 2022 17:55 UTC
Sragovicz AdamChief Financial Officer
GrantCommon Stock - Series A 71,827 $3.81 $273,660.87
Disclosure

SEC source: 0001209191-22-002321 · doc4.xml · nonDerivative · entry 1

Sragovicz Adam · CIK 0001727723 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 130,679

F1 · shares: Restricted shares granted pursuant to the Company's 2017 Incentive Award Plan. These shares vest evenly over a three (3) year period at the end of each calendar year.

F2 · price: Reflects trailing 20 day average closing price for grants issued.

Read SEC document
January 03, 2022 Filed Jan 7, 2022 17:44 UTC
KATZ GARY MORRISSVP, Asset Management
GrantCOMMON STOCK - SERIES A 22,068 $3.81 $84,079.08
Disclosure

SEC source: 0001209191-22-002320 · doc4.xml · nonDerivative · entry 2

KATZ GARY MORRIS · CIK 0001764243 · SVP, Asset Management

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 171,642

F3 · shares: Restricted shares granted pursuant to the Company's 2017 Incentive Award Plan. These shares vest on the date of grant.

F2 · price: Reflects trailing 20 day average closing price for grants issued.

Read SEC document
January 03, 2022 Filed Jan 7, 2022 17:44 UTC
KATZ GARY MORRISSVP, Asset Management
GrantCOMMON STOCK - SERIES A 71,827 $3.81 $273,660.87
Disclosure

SEC source: 0001209191-22-002320 · doc4.xml · nonDerivative · entry 1

KATZ GARY MORRIS · CIK 0001764243 · SVP, Asset Management

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 149,574

F1 · shares: Restricted shares granted pursuant to the Company's 2017 Incentive Award Plan. These shares vest evenly over a three (3) year period at the end of each calendar year.

F2 · price: Reflects trailing 20 day average closing price for grants issued.

Read SEC document
December 21, 2021 Filed Dec 22, 2021 14:58 UTC
Heilbron Jack KendrickDirector · CEO and President
PurchasePreferred Stock - Series D 500 $21.04 $10,520.00
Disclosure

SEC source: 0001209191-21-070888 · doc4.xml · nonDerivative · entry 1

Heilbron Jack Kendrick · CIK 0001437208 · Director · CEO and President

10b5-1 filing: Not disclosed

Ownership: Indirect · Held by Puppy Toes, Inc.

Disclosed balance after: 1,900

Read SEC document
December 17, 2021 Filed Dec 20, 2021 22:36 UTC
Heilbron Jack KendrickDirector · CEO and President
PurchasePreferred Stock - Series D 300 $22.51 $6,753.00
Disclosure

SEC source: 0001209191-21-070618 · doc4.xml · nonDerivative · entry 1

Heilbron Jack Kendrick · CIK 0001437208 · Director · CEO and President

10b5-1 filing: Not disclosed

Ownership: Indirect · Held by Puppy Toes, Inc.

Disclosed balance after: 1,400

Read SEC document
December 06, 2021 Filed Dec 6, 2021 22:02 UTC
Heilbron Jack KendrickDirector · CEO and President
PurchaseCommon Stock - Series A 1,100 $3.53 $3,883.00
Disclosure

SEC source: 0001209191-21-068126 · doc4.xml · nonDerivative · entry 1

Heilbron Jack Kendrick · CIK 0001437208 · Director · CEO and President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 198,840

F1 · balance_after: The balance includes: (i) 600 shares (less than 0.5% of holdings reported) held by or FBO the Reporting Person's grandchildren, and (ii) shares held in Reporting Person's IRA.

Read SEC document
December 03, 2021 Filed Dec 6, 2021 22:43 UTC
Bruen DavidDirector
GrantCOMMON STOCK - SERIES A 2,626 $3.81 $10,005.06
Disclosure

SEC source: 0001209191-21-068148 · doc4.xml · nonDerivative · entry 1

Bruen David · CIK 0001456713 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 38,369

Read SEC document
December 03, 2021 Filed Dec 6, 2021 22:57 UTC GrantCOMMON STOCK - SERIES A 5,252 $3.81 $20,010.12
Disclosure

SEC source: 0001209191-21-068164 · doc4.xml · nonDerivative · entry 1

Rollings Sumner James · CIK 0001437209 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 54,696

Read SEC document
December 03, 2021 Filed Dec 6, 2021 22:50 UTC GrantCOMMON STOCK - SERIES A 5,252 $3.81 $20,010.12
Disclosure

SEC source: 0001209191-21-068157 · doc4.xml · nonDerivative · entry 1

DURFEY JAMES ROBERT · CIK 0001797416 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 39,375

Read SEC document
December 03, 2021 Filed Dec 6, 2021 22:34 UTC GrantCOMMON STOCK - SERIES A 5,252 $3.81 $20,010.12
Disclosure

SEC source: 0001209191-21-068140 · doc4.xml · nonDerivative · entry 1

BARNES JENNIFER A · CIK 0001806097 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,435

Read SEC document
December 01, 2021 Filed Dec 2, 2021 23:50 UTC
Sragovicz AdamChief Financial Officer
PurchasePreferred Stock - Series D 500 $23.50 $11,750.00
Disclosure

SEC source: 0001209191-21-067704 · doc4.xml · nonDerivative · entry 1

Sragovicz Adam · CIK 0001727723 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,500

Read SEC document
December 01, 2021 Filed Dec 2, 2021 22:59 UTC
Heilbron Jack KendrickDirector · CEO and President
PurchasePreferred Stock - Series D 300 $23.41 $7,023.00
Disclosure

SEC source: 0001209191-21-067699 · doc4.xml · nonDerivative · entry 1

Heilbron Jack Kendrick · CIK 0001437208 · Director · CEO and President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,400

Read SEC document
September 20, 2021 Filed Sep 27, 2021 21:36 UTC
Heilbron Jack KendrickDirector · CEO and President
PurchaseCommon Stock - Series A 496 $3.49 $1,731.04
Disclosure

SEC source: 0001209191-21-057820 · doc4.xml · nonDerivative · entry 2

Heilbron Jack Kendrick · CIK 0001437208 · Director · CEO and President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 192,640

F1 · balance_after: The balance includes: (i) 600 shares (less than 0.5% of holdings reported) held by or FBO the Reporting Person's grandchildren, and (ii) shares held in Reporting Person's IRA.

Read SEC document
September 20, 2021 Filed Sep 27, 2021 21:36 UTC
Heilbron Jack KendrickDirector · CEO and President
PurchaseCommon Stock - Series A 110 $3.40 $374.00
Disclosure

SEC source: 0001209191-21-057820 · doc4.xml · nonDerivative · entry 1

Heilbron Jack Kendrick · CIK 0001437208 · Director · CEO and President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 192,144

F1 · balance_after: The balance includes: (i) 600 shares (less than 0.5% of holdings reported) held by or FBO the Reporting Person's grandchildren, and (ii) shares held in Reporting Person's IRA.

Read SEC document
September 20, 2021 Filed Oct 28, 2021 19:46 UTC
Heilbron Jack KendrickDirector · CEO and President
PurchaseCommon Stock - Series A 5,100 $3.50 $17,850.00
Disclosure

SEC source: 0001209191-21-061879 · doc4.xml · nonDerivative · entry 1

Heilbron Jack Kendrick · CIK 0001437208 · Director · CEO and President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 197,740

F1 · balance_after: The balance includes: (i) 600 shares (less than 0.5% of holdings reported) held by or FBO the Reporting Person's grandchildren, and (ii) shares held in Reporting Person's IRA.

Read SEC document
August 19, 2021 Filed Aug 23, 2021 16:19 UTC
Heilbron Jack KendrickDirector · CEO and President
PurchaseCommon Stock - Series A 165 $3.65 $602.25
Disclosure

SEC source: 0001209191-21-052901 · doc4.xml · nonDerivative · entry 1

Heilbron Jack Kendrick · CIK 0001437208 · Director · CEO and President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 192,034

F1 · shares: Reporting Person is the controlling shareholder of Jackson Heilbron.

F2 · balance_after: The balance includes: (i) 600 shares (less than 0.5% of holdings reported) held by or FBO the Reporting Person's grandchildren, and (ii) shares held in Reporting Person's IRA.

Read SEC document
August 18, 2021 Filed Aug 18, 2021 23:43 UTC PurchaseCOMMON STOCK - SERIES A 2,000 $3.69 $7,381.00
Disclosure

SEC source: 0001209191-21-052417 · doc4.xml · nonDerivative · entry 2

DURFEY JAMES ROBERT · CIK 0001797416 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · Held by Custodian FBO Natalia R. Marchese

Disclosed balance after: 2,000

F2 · ownership.nature: Reporting Person is the controlling shareholder of Natalia R Marchese UTMA.

Read SEC document
August 17, 2021 Filed Aug 18, 2021 23:43 UTC PurchaseCOMMON STOCK - SERIES A 10,000 $3.60 $36,000.00
Disclosure

SEC source: 0001209191-21-052417 · doc4.xml · nonDerivative · entry 1

DURFEY JAMES ROBERT · CIK 0001797416 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,123

F1 · balance_after: The balance includes 2,000 shares held by or FBO the Reporting Person's grandchildren.

Read SEC document
August 16, 2021 Filed Aug 16, 2021 22:52 UTC
Dubose Larry GeneDirector · D&O of affiliated companies
PurchaseCommon Stock - Series A 827 $3.51 $2,902.77
Disclosure

SEC source: 0001209191-21-051691 · doc4.xml · nonDerivative · entry 2

Dubose Larry Gene · CIK 0001438084 · Director · D&O of affiliated companies

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 123,441

Read SEC document
August 16, 2021 Filed Aug 17, 2021 22:26 UTC
Heilbron Jack KendrickDirector · CEO and President
PurchaseCommon Stock - Series A 300 $3.54 $1,062.00
Disclosure

SEC source: 0001209191-21-052014 · doc4.xml · nonDerivative · entry 2

Heilbron Jack Kendrick · CIK 0001437208 · Director · CEO and President

10b5-1 filing: Not disclosed

Ownership: Indirect · Held by Custodian FBO Connor Daniel Heilbron

Disclosed balance after: 300

F2 · ownership.nature: Reporting Person is the controlling shareholder of Connor Daniel Heilbron UGMA.

Read SEC document
August 16, 2021 Filed Aug 17, 2021 22:26 UTC
Heilbron Jack KendrickDirector · CEO and President
PurchaseCommon Stock - Series A 1,000 $3.57 $3,570.00
Disclosure

SEC source: 0001209191-21-052014 · doc4.xml · nonDerivative · entry 1

Heilbron Jack Kendrick · CIK 0001437208 · Director · CEO and President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 191,869

F1 · balance_after: The balance includes: (i) 435 shares (less than 0.5% of holdings reported) held by or FBO the Reporting Person's grandchildren, and (ii) shares held in Reporting Person's IRA.

Read SEC document
August 13, 2021 Filed Aug 16, 2021 22:52 UTC
Dubose Larry GeneDirector · D&O of affiliated companies
PurchaseCommon Stock - Series A 7,400 $3.61 $26,714.00
Disclosure

SEC source: 0001209191-21-051691 · doc4.xml · nonDerivative · entry 1

Dubose Larry Gene · CIK 0001438084 · Director · D&O of affiliated companies

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 122,614

Read SEC document
August 13, 2021 Filed Aug 16, 2021 22:47 UTC GrantCOMMON STOCK - SERIES A 4,650 $3.69 $17,158.50
Disclosure

SEC source: 0001209191-21-051688 · doc4.xml · nonDerivative · entry 1

DURFEY JAMES ROBERT · CIK 0001797416 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,123

Read SEC document
August 13, 2021 Filed Aug 16, 2021 22:43 UTC GrantCOMMON STOCK - SERIES A 1,395 $3.69 $5,147.55
Disclosure

SEC source: 0001209191-21-051686 · doc4.xml · nonDerivative · entry 1

BARNES JENNIFER A · CIK 0001806097 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,183

Read SEC document
August 13, 2021 Filed Aug 16, 2021 22:45 UTC
Bruen DavidDirector
GrantCOMMON STOCK - SERIES A 2,325 $3.69 $8,579.25
Disclosure

SEC source: 0001209191-21-051687 · doc4.xml · nonDerivative · entry 1

Bruen David · CIK 0001456713 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,743

Read SEC document
August 13, 2021 Filed Aug 16, 2021 22:40 UTC GrantCOMMON STOCK - SERIES A 4,650 $3.69 $17,158.50
Disclosure

SEC source: 0001209191-21-051685 · doc4.xml · nonDerivative · entry 1

Rollings Sumner James · CIK 0001437209 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 49,444

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.